A new study, affiliated with UNIST confirms that targeting SnCs could treat age-related degenerative joint disease.
A recent study, led by an international team of researchers confirms that targeted removal of senescent cells (SnCs), accumulated in many vertebrate tissues as we age, contribute significantly in delaying the onset of age-related pathologies.
This breakthrough research has been led by Dr. Chaekyu Kim of the Johns Hopkins University School of Medicine, who is now at UNIST, and Dr. Ok Hee Jeon of the Johns Hopkins University School of Medicine in collaborations with the Mayo Clinic College of Medicine, the Buck Institute for Research on Aging, the University Medical Center Groningen, Unity Biotechnology, Inc., and the University of California, Berkeley.
In the study, the research team presented a novel pharmacologic candidate that alleviates age-related degenerative joint conditions, such as osteoarthritis (OA) by selectively destroying SnCs. Their findings, published April 24th in Nature Medicine (Impact Factor: 30.357), suggest that the selective removal of old cells from joints could reduce the development of post-traumatic OA and allow new cartilage to grow and repair joints.
Senescent cells (SnCs) accumulate with age in many vertebrate tissues and are present at sites of age-related pathlogy. Although these cells play an essential role in wound healing and injury repair, they may also promote cancer incidence in tissues. For instance, in articular joints, such as the knee and cartilage tissue, SnCs often are not cleared from the area after injury, thereby contributing to OA development.
To test the idea that SnCs might play a causative role in OA, the research team took both younger and older mice and cut their anterior cruciate ligaments (ACL) to minic injury. They, then, administered injections of an experimental drug, named UBX0101 to selectively remove SnCs after anterior cruciate ligament transection (ACLT) surgery.
Preclinical studies in mice and human cells suggested that the removal of SnCs significantly reduced the development of post-traumatic OA and related pain and created a prochondrogenic environment for new cartilage to grow and repair joints. Indeed, the research team reported that aged mice did not exhibit signs of cartilage regeneration after treatment with UBX0101 injections,
According to the research team, the relevance of their findings to human disease was validated using chondrocytes isolated from arthritic patients. The research team notes that their findings provide new insights into therapies targeting SnCs for the treatment of trauma and age-related degenerative joint disease.
Prior to this study, Johns Hopkins Technology Ventures (JHTV) granted UNITY Biotechnology Inc. the right to use the intellectual property around the senescent cell technology. UNITY is a company aiming to develop therapeutics that address age-related diseases. Last October, the company announced $116 million in Series B funding from some of the big names in venture capital, including Amazon CEO Jeff Bezo’s venture fund Bezos Expeditions, Mayo Clinic Ventures, Venrock, and ARCH Venture Partners. UNITY has completed a rigorous screening and preclinical testing process of candidate drugs, discovered in this study, and is launching a new clinical trial to assess its first drug, for patients with osteoarthritis of the knee this year.
Learn more: Removal of Aging Cells Could Extend Human Life
The Latest on: Extended human life
- Human Fatherhood is Diverse: They Do What They Need To Do on December 15, 2018 at 12:47 pm
Become a supporter and enjoy The Good Men Project ad free We believe the main reason for this is job mobility – as parents live further away from extended ... life. One of the great strengths of ... […]
- 'I think he is a terrible human being': Embarrassment for Trump's new chief of staff Mick Mulvaney as video emerges of him revealing his contempt for the President during 2016 ... on December 15, 2018 at 3:39 am
Video has emerged showing incoming White House Chief of Staff Mick Mulvaney trashing Donald Trump as a 'terrible human being' during the 2016 election ... that Mulvaney could fill the position for an ... […]
- Human value source of human rights on December 13, 2018 at 8:45 am
The few had everything, including hereditary blessings, while the vast majority had their inheritance as well – a life of poverty. With our background of extended massive poverty, all human rights dec... […]
- Thoughtful Human's Line of Plantable Greeting Cards Is Here for Life's Most Delicate Scenarios on December 12, 2018 at 12:07 am
Thoughtful Human In a video posted to the company's website, Thoughtful Human's founder, Ali O'Grady, explains that the cards are designed for "dynamic relationships and challenging life ... […]
- Movers, Shakers & Policymakers - Dorothy Hoddinott, human rights champion on December 11, 2018 at 7:13 pm
Dorothy has spent much of her life as a tireless and fierce advocate of human rights, variously lobbying ... It’s been an amazing life, but there’s much to do yet. Besides some extended time in Europe ... […]
via Google News and Bing News